June 13, 2026
FesariusTherapeutics
FesariusTherapeutics raised $20 million to scale the commercialization of its DermiSphere dermal regeneration template and advance a clinical trial.
- Round
- Other
- Amount raised
- $20M
- Lead investor
- —
- Industry
- Biotechnology, Medical Devices
- Headquarters
- —
- Employees
- 2-10 employees
- Website
- fesariustherapeutics.com
- View profile →